EUROAPI SASU (EAPI.PA) Fundamental Analysis & Valuation

EPA:EAPI • FR0014008VX5

Current stock price

1.265 EUR
-0.04 (-2.69%)
Last:

This EAPI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. EAPI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year EAPI has reported negative net income.
  • In the past year EAPI had a positive cash flow from operations.
  • EAPI had negative earnings in each of the past 5 years.
  • In the past 5 years EAPI always reported a positive cash flow from operatings.
EAPI.PA Yearly Net Income VS EBIT VS OCF VS FCFEAPI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • EAPI has a worse Return On Assets (-16.19%) than 75.00% of its industry peers.
  • EAPI has a Return On Equity of -26.80%. This is in the lower half of the industry: EAPI underperforms 76.92% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.26%, EAPI is doing worse than 67.31% of the companies in the same industry.
Industry RankSector Rank
ROA -16.19%
ROE -26.8%
ROIC 0.26%
ROA(3y)-12.24%
ROA(5y)-7.62%
ROE(3y)-20.18%
ROE(5y)-12.54%
ROIC(3y)N/A
ROIC(5y)N/A
EAPI.PA Yearly ROA, ROE, ROICEAPI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -5 -10 -15 -20 -25

1.3 Margins

  • EAPI has a Operating Margin of 0.43%. This is in the lower half of the industry: EAPI underperforms 67.31% of its industry peers.
  • EAPI's Operating Margin has declined in the last couple of years.
  • The Gross Margin of EAPI (17.00%) is worse than 80.77% of its industry peers.
  • EAPI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.43%
PM (TTM) N/A
GM 17%
OM growth 3Y-46.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y12.15%
EAPI.PA Yearly Profit, Operating, Gross MarginsEAPI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. EAPI.PA Health Analysis

2.1 Basic Checks

  • EAPI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, EAPI has about the same amount of shares outstanding.
  • EAPI has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EAPI is higher compared to a year ago.
EAPI.PA Yearly Shares OutstandingEAPI.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
EAPI.PA Yearly Total Debt VS Total AssetsEAPI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • The Debt to FCF ratio of EAPI is 1.31, which is an excellent value as it means it would take EAPI, only 1.31 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 1.31, EAPI belongs to the best of the industry, outperforming 86.54% of the companies in the same industry.
  • A Debt/Equity ratio of 0.08 indicates that EAPI is not too dependend on debt financing.
  • EAPI's Debt to Equity ratio of 0.08 is amongst the best of the industry. EAPI outperforms 82.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.31
Altman-Z N/A
ROIC/WACC0.04
WACC7.29%
EAPI.PA Yearly LT Debt VS Equity VS FCFEAPI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.60 indicates that EAPI has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 2.60, EAPI belongs to the best of the industry, outperforming 82.69% of the companies in the same industry.
  • EAPI has a Quick Ratio of 2.60. This is a bad value and indicates that EAPI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EAPI has a Quick ratio (0.93) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 0.93
EAPI.PA Yearly Current Assets VS Current LiabilitesEAPI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EAPI.PA Growth Analysis

3.1 Past

  • The earnings per share for EAPI have decreased strongly by -61.42% in the last year.
  • The Revenue has decreased by -7.25% in the past year.
  • EAPI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.03% yearly.
EPS 1Y (TTM)-61.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.51%
Revenue 1Y (TTM)-7.25%
Revenue growth 3Y-4.57%
Revenue growth 5Y-2.03%
Sales Q2Q%-6.45%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.37% on average over the next years. This is a very strong growth
  • EAPI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.57% yearly.
EPS Next Y63.82%
EPS Next 2Y49.03%
EPS Next 3Y37.35%
EPS Next 5Y25.37%
Revenue Next Year-11.29%
Revenue Next 2Y-4.41%
Revenue Next 3Y-1.76%
Revenue Next 5Y2.57%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EAPI.PA Yearly Revenue VS EstimatesEAPI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
EAPI.PA Yearly EPS VS EstimatesEAPI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4

More info and screens

Find the best growth stocksShow best growing peers

3

4. EAPI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EAPI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EAPI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EAPI.PA Price Earnings VS Forward Price EarningsEAPI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • EAPI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EAPI is cheaper than 100.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EAPI indicates a rather cheap valuation: EAPI is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.41
EV/EBITDA 0.19
EAPI.PA Per share dataEAPI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EAPI's earnings are expected to grow with 37.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.03%
EPS Next 3Y37.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EAPI.PA Dividend Analysis

5.1 Amount

  • EAPI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EAPI.PA Fundamentals: All Metrics, Ratios and Statistics

EUROAPI SASU

EPA:EAPI (4/2/2026, 7:00:00 PM)

1.265

-0.04 (-2.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-03
Earnings (Next)07-28
Inst Owners36.18%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap120.92M
Revenue(TTM)852.60M
Net Income(TTM)-211.20M
Analysts44.62
Price Target2.3 (81.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.25%
PT rev (3m)-16.04%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-700%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.58%
Revenue NY rev (3m)-8.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF 2.41
P/OCF 0.94
P/B 0.15
P/tB 0.16
EV/EBITDA 0.19
EPS(TTM)-2.23
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)0.52
FCFY41.43%
OCF(TTM)1.35
OCFY106.35%
SpS8.92
BVpS8.24
TBVpS7.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.19%
ROE -26.8%
ROCE 0.37%
ROIC 0.26%
ROICexc 0.29%
ROICexgc 0.3%
OM 0.43%
PM (TTM) N/A
GM 17%
FCFM 5.88%
ROA(3y)-12.24%
ROA(5y)-7.62%
ROE(3y)-20.18%
ROE(5y)-12.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-42.45%
ROICexgc growth 5YN/A
ROICexc growth 3Y-42.58%
ROICexc growth 5YN/A
OM growth 3Y-46.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y12.15%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.31
Debt/EBITDA 0.43
Cap/Depr 55.87%
Cap/Sales 9.21%
Interest Coverage 1.23
Cash Conversion 89.18%
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 0.93
Altman-Z N/A
F-Score5
WACC7.29%
ROIC/WACC0.04
Cap/Depr(3y)80.11%
Cap/Depr(5y)106.81%
Cap/Sales(3y)11.33%
Cap/Sales(5y)12.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.51%
EPS Next Y63.82%
EPS Next 2Y49.03%
EPS Next 3Y37.35%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-7.25%
Revenue growth 3Y-4.57%
Revenue growth 5Y-2.03%
Sales Q2Q%-6.45%
Revenue Next Year-11.29%
Revenue Next 2Y-4.41%
Revenue Next 3Y-1.76%
Revenue Next 5Y2.57%
EBIT growth 1Y143.53%
EBIT growth 3Y-48.51%
EBIT growth 5YN/A
EBIT Next Year250.3%
EBIT Next 3Y65.19%
EBIT Next 5Y37.5%
FCF growth 1Y236.24%
FCF growth 3YN/A
FCF growth 5Y42.93%
OCF growth 1Y4.64%
OCF growth 3Y42.12%
OCF growth 5Y5.85%

EUROAPI SASU / EAPI.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EUROAPI SASU?

ChartMill assigns a fundamental rating of 3 / 10 to EAPI.PA.


What is the valuation status for EAPI stock?

ChartMill assigns a valuation rating of 3 / 10 to EUROAPI SASU (EAPI.PA). This can be considered as Overvalued.


Can you provide the profitability details for EUROAPI SASU?

EUROAPI SASU (EAPI.PA) has a profitability rating of 2 / 10.


What is the expected EPS growth for EUROAPI SASU (EAPI.PA) stock?

The Earnings per Share (EPS) of EUROAPI SASU (EAPI.PA) is expected to grow by 63.82% in the next year.